It looks like PharmAthene (PIP +7.7%) investors will be in for another roller coaster of a session as the stock jumps out of the gate after the FDA lifts its clinical hold on the company's SparVax vaccine program. (Recently: PIP/SIGA claim legal victory) (PR)
It looks like PharmAthene (PIP +7.7%) investors will be in for another roller coaster of a...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs